Who
Thomas Anderson
Director
Company insider
Files Form 4 as: Director, Zevra Therapeutics; Officer, Sage Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 3
- Sells
- 3
- Bought
- $225K
- Sold
- $1.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 23 Jul 2014
- Last trade
- 4 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 18 Jun 2026 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 4 Jun 2026filed 18 Jun 2026 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 16 Jul 2024filed 16 Jul 2024 | ZVRA Zevra TherapeuticsBiotechnology | SEC FORM 4 Bought | $68K10,000 at $6.81 | filing |
| 13 May 2024filed 15 May 2024 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,200 at $0.00 | filing |
| 6 Sep 2023filed 6 Sep 2023 | ZVRA Zevra TherapeuticsBiotechnology | SEC FORM 4 Bought | $49K10,000 at $4.88 | filing |
| 7 Aug 2023filed 25 Aug 2023 | ZVRA Zevra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,800 at $0.00 | filing |
| 6 Feb 2017filed 8 Feb 2017 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 15 Dec 2016filed 19 Dec 2016 | Sage Therapeutics | SEC FORM 4 Code M | $17K1,900 at $8.92 | filing |
| 15 Dec 2016filed 19 Dec 2016 | Sage Therapeutics | SEC FORM 4 Code F | $17K346 at $48.99 | filing |
| 15 Dec 2016filed 19 Dec 2016 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code M | —1,900 at $0.00 | filing |
| 8 Dec 2016filed 16 Dec 2016 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code A | —12,600 at $0.00 | filing |
| 15 Nov 2016filed 28 Nov 2016 | Sage Therapeutics | SEC FORM 4 Code M | $89K10,000 at $8.92 | filing |
| 15 Nov 2016filed 28 Nov 2016 | Sage Therapeutics | SEC FORM 4 Sold | $550K10,000 at $55.00 | filing |
| 15 Nov 2016filed 28 Nov 2016 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 8 Feb 2016filed 10 Feb 2016 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 10 Aug 2015filed 11 Aug 2015 | Sage Therapeutics | SEC FORM 4 Sold | $235K3,480 at $67.66 | filing |
| 10 Aug 2015filed 11 Aug 2015 | Sage Therapeutics | SEC FORM 4 Sold | $82K1,220 at $67.14 | filing |
| 10 Aug 2015filed 11 Aug 2015 | Sage Therapeutics | SEC FORM 4 Sold | $85K1,300 at $65.34 | filing |
| 8 Jun 2015filed 8 Jun 2015 | Sage Therapeutics | SEC FORM 4 Code M | $49K5,500 at $8.92 | filing |
News
Thomas Anderson Leads Beeefer Brewers Fayre Restaurant Acquisition of 57 Sitesel-balad.com · 7 Oct 2026Cameron Winter and Paul Thomas Anderson Interview, BTSvulture.com · 1 Oct 2026One Of Paul Thomas Anderson's Best Movies Is Always Overshadowed, Despite Starring A Legendcinemablend.com · 20 Sep 2026Naomi Watts Says She'd Like To Work With Paul Thomas Andersondeadline.com · 19 Sep 2026Thomas anderson stories at Techdirt.techdirt.com · 8 Sep 2026London Film Festival Adds Paul Thomas Anderson's Cameron Winter Filmdeadline.com · 7 Sep 2026
6 headlines in the last 90 days name Thomas Anderson; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.